Contact Us | Volunteer | Donate

Our mission is to raise public awareness of Brain Cancer, raise money for the UCLA Neuro-Oncology Program, and spotlight the talent, strength and courage of brain cancer patients.
Next Event

SAVE THE DATE
Art of the Brain 12th Annual Gala
UCLA Schoenberg Hall Auditorium and Courtyard
 
Saturday, October 1, 2011
6:30 P.M.
 
Join us on October 1, 2011 to celebrate Art of the Brain's 12th Annual Gala.  We will show our solidarity with the courageous men and women facing brain cancer and pay tribute to the unforgettable individuals we have sadly lost.  We will celebrate their talent and zest for life with a festival of gourmet food and wine.  There will also be a fabulous raffle and special performances.
 
> Invitation
> RSVP
> Map & Directions

Corporate Partners

 

2011 Corporate Sponsors

 
 
NETWORK SPONSORS
 
 
  
LEGACY SPONSORS
 
Robert & Jennifer Lopata
Afsaneh & Faramarz Yousefzadeh / STM Group, Inc.
 
 
COURAGE SPONSORS
 
City National Bank
Joan and Gerald Doren
Gang Tyre Ramer & Brown
Judi & Roy Kaufman
Ann Ramer
Cookie Shapiro
 
 
GRATITUDE SPONSORS
 
Richard Dean Anderson
Joyce and William Bromiley
Marlene and David Capell
Clint and Dina Eastwood
Valerie and Robert Fairbank
Gold Family Foundation
Karen and George Grengs / Valterra Products, Inc.
Richard and Sue Masson
Mitra & Bahram Nabati / Pioneer Distributors, Inc.
Bob & Virginia Newhart
Benedicta and Geoffry Oblath
Mary Rooney
Ruby Family Foundation
The Barbera Hale Thornhill Fund
Gy and Jadi Waldron
Bunny Wasser and Howard Bernstein
Wells Fargo
 Cynthia and Bud Yorkin
 
 
*Please check back often for an updated list of sponsors.
 
 
 
Art of the Brain wishes to thank all of our sponsors for their support!
 

Whats New: Art of the Brain
Art of the Brain 11th Annual Gala: “The Gleeful Art of Sportsmanship”
10/3/2010 8:00 AM PST [ArtOfTheBrain.org]
Judi Kaufman: Brain cancer survivor founds nonprofit Art of the Brain to help other patients
10/20/2008 8:00 AM PST [Los Angeles Times]
Local Entrepreneur Judi Kaufman Fights Back Against Brain Cancer
10/12/2008 8:00 AM PST [Beverly Hills Courier]
Cancer survivor brings art, courage to other patients
9/17/2008 8:00 AM PST [The Jewish Journal]
Art of the Brain 8th Annual Gala - An Inspirational Global Pursuit for the Cure
4/1/2008 8:00 AM PST [BreakthroughsMag]

Brain Cancer Research In The News
American Brain Tumor Association Names Student Research Award Winner
Tue, 31 Jan 2012 09:52:37 -0800
The Florida Brain Tumor Association Announces a $600,000 Gift for the Advancement of Pediatric Brain Cancer Research
Mon, 30 Jan 2012 04:03:03 -0800
American Brain Tumor Association Announces “Breakthrough for Brain Tumors” 5K Event
Thu, 02 Feb 2012 09:46:57 -0800
Brain Tumor Gene Mutations Discovered in Early Childhood Cases
Wed, 01 Feb 2012 08:20:49 -0800
Super Bowl Special: An In-depth Look At A Young Woman Battling A Brain Tumor
Sun, 05 Feb 2012 15:37:03 -0800
Henry Ford Hospital: First in U.S. to Start New Clinical Trial For Innovative Treatment Under Investigation for ...
Tue, 31 Jan 2012 08:39:00 -0800
Diagnostic brain tumor test could revolutionize care of patients
Fri, 27 Jan 2012 06:48:56 -0800
Middlesex County man battles brain tumor with help of technology, clinical trial
Mon, 23 Jan 2012 21:03:48 -0800
Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With ...
Fri, 03 Feb 2012 05:00:00 -0800
Abnormal chromosome indicates outcome for rare brain tumor
Sun, 22 Jan 2012 19:27:57 -0800

Recent Initiatives funded in part by Art of the Brain
It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.


Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.


Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.


Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.


Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab.
J Neurooncol.


Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab.
Magn Reson Med.


Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept.
Clin Cancer Res.


International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.
Neuro Oncol.


Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.
AJNR Am J Neuroradiol.


AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme.
Adv Ther.


Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.Portions Copyright (Search, Chart, Content Publishing Tools) 1998-2012 SiliconMED

© 2012 Artofthebrain.org
All Rights Reserved.

[Content Published:2/6/2012 5:01:11 PM PST]